An announcement from the Asian Development Bank (ADB) on Friday reads that it has launched a USD 9 billion vaccine initiative that will offer support to its developing member economies to buy and deliver COVID-19 vaccines. The release informs that ADB has launched a USD 9 billion vaccine initiative, the Asia Pacific Vaccine Access Facility (APVAX) offering rapid and equitable support to its developing members as they procure and deliver effective and safe coronavirus disease (COVID-19) vaccines.
ADB President Masatsugu Asakawa said, "As ADB''s developing members prepare to vaccinate their people as soon as possible, they need financing to procure vaccines as well as appropriate plans and knowledge to be able to safely, equitably, and efficiently manage the vaccination process". He further noted that "APVAX will play a critical role in helping our developing members meet these challenges, overcome the pandemic, and focus on economic recovery."
In the Asia and the Pacific region, ADB said more than 14.3 million positive cases have been identified, causing more than 2,00,000 deaths. As the pandemic continues, economic growth in developing Asia is projected to contract by 0.4 per cent in 2020 and is the first regional gross domestic product contraction since the early 1960s, it added.
COVAX scheme to provide 500 million vaccine doses in 2021 first quarter
'Homegrown corona vaccine has no side-effect' claims female doctor taking first dose of Covaxin
Asian Development bank to fund USD 2.5 million towards advanced biofuel development in India